Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study - Top-Institutions - MDSpire

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

  • By

  • Ma Wanda

  • Lei Mengjie

  • Wang Jingyao

  • Sun Xue

  • Wang Xiao

  • Li Cairong

  • Li Yachao

  • Zhao Zhigang

  • Xue Zengming

  • May 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Langfang People’s Hospital
    Langfang People’s Hospital

    Langfang, Hebei

    Key Differentiators

    • Cardiology

  • #2

    University Hospital of Heidelberg
    University Hospital of Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Cardiology

  • #3

    Policlinico Gemelli
    Policlinico Gemelli

    Rome, Lazio

    Key Differentiators

    • Cardiology

Original Source(s)

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

  • by Ma Wanda, Lei Mengjie, Wang Jingyao, Sun Xue, Wang Xiao, Li Cairong, Li Yachao, Zhao Zhigang, Xue Zengming

  • May 1, 2026

Related Content

Medical Oddities: Muscle Memory Before Birth? 

When dad trains offspring gain, bar tricks can end in the OR, guts that linger, empathetic pain, and “natural” immune traps this week.

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering